Pamela Sutherland v. DCC Litig. Facility ( 2017 )


Menu:
  •                 NOT RECOMMENDED FOR FULL-TEXT PUBLICATION
    File Name: 17a0594n.06
    Nos. 16-2396, 16-2397                            FILED
    Oct 31, 2017
    UNITED STATES COURT OF APPEALS
    DEBORAH S. HUNT, Clerk
    FOR THE SIXTH CIRCUIT
    KATHY JEAN GATZA (16-2396); PAMELA )
    D. SUTHERLAND (16-2397),           )
    )
    ON APPEAL FROM THE
    Plaintiffs-Appellants,       )
    UNITED STATES DISTRICT
    )
    COURT FOR THE EASTERN
    v.                                 )
    DISTRICT OF MICHIGAN
    )
    DCC LITIGATION FACILITY,           )
    INCORPORATED,                      )
    OPINION
    )
    Defendant-Appellee.          )
    )
    Before: MERRITT, MOORE, and ROGERS, Circuit Judges.
    KAREN NELSON MOORE, Circuit Judge. Plaintiffs-Appellants Kathy Gatza and
    Pamela Sutherland (together, “Plaintiffs”) appeal the district court’s denial of their motions to
    amend the scheduling orders in their cases. Before the expert-disclosure deadlines passed,
    Plaintiffs did not disclose Dr. Arthur Brawer as an expert witness. For the reasons discussed
    below, we AFFIRM the district court’s denial of the motions to amend the scheduling orders.
    Gatza also appeals the district court’s decision to grant Defendant-Appellee DCC Litigation
    Facility, Inc.’s (“DCC”) motion for summary judgment because Wisconsin’s statute of
    limitations bars her claims. We do not address Gatza’s argument in this regard because, without
    an opportunity to amend the scheduling order, Gatza cannot prove causation, and so the
    limitations issue is moot.
    No. 16-2396/ 2397Gatza et al. v. DCC Litigation Facility, Inc.
    I. BACKGROUND
    Dow Corning Corporation (“Dow”) was the leading manufacturer of silicone-breast
    implants. Lindsey v. O’Brien (In re Dow Corning Corp.), 
    86 F.3d 482
    , 485 (6th Cir. 1996).
    Then, in the early 1990s, thousands of implant recipients began to file actions alleging that
    Dow’s silicone-breast implants caused health problems. Sutherland v. DCC Litig. Facility, Inc.
    (In re Dow Corning Corp.), 
    778 F.3d 545
    , 547 (6th Cir. 2015). Eventually, in the Northern
    District of Alabama, a class-settlement agreement was reached. 
    Id.
     at 547–48. Roughly 440,000
    individuals agreed with this settlement, but thousands of individuals opted out. Lindsey, 
    86 F.3d at
    485–86.
    Because this was “one of the world’s largest mass tort litigations,” Dow filed for
    reorganization under the Bankruptcy Code in the Eastern District of Michigan. 
    Id. at 486
    .
    Dow’s filing stayed all related actions. 
    Id.
     Additionally, the Eastern District of Michigan
    received all of the actions connected to the bankruptcy proceeding. Sutherland, 778 F.3d at 548.
    The bankruptcy court authorized an “Amended Joint Plan of Reorganization.” Ezra v.
    DCC Litig. Facility, Inc., 667 F. App’x 538, 538–39 (6th Cir. 2016). Under this plan, a plaintiff
    could litigate individual claims against DCC, Dow’s litigation corporation, or accept payments
    under the plan. Id. at 539. Both Gatza and Sutherland chose to litigate their claims. No. I:05-
    cv-30276-DPH R. 1 (Notice of Intent to Litigate) (Page ID #1) (Sutherland); No. I:05-cv-30496-
    DPH R. 1 (Notice of Intent to Litigate) (Page ID #1) (Gatza).
    In Gatza’s action, the district court examined several relevant motions. First, the district
    court denied Gatza’s request to extend the expert-disclosure deadline. No. I:5-cv-30496 DPH R.
    2
    No. 16-2396/ 2397Gatza et al. v. DCC Litigation Facility, Inc.
    167 (Order at 3–7) (Page ID #6829–33). Next, the district court granted DCC’s motion to
    exclude the opinions of Dr. Pierre Blais, Dr. Jerry Bush, and Dr. Justus Fiechtner. Id. at 20
    (Page ID #6846).     Lastly, the district court granted DCC’s renewed motion for summary
    judgment because, without an expert, Gatza could not prove causation, and also because
    Wisconsin’s statute of limitations bars Gatza’s claims. Id. at 24, 26 (Page ID #6850, 6852).
    Gatza now appeals two aspects of the district court’s order: its decision (1) to deny Gatza’s
    request to extend the expert-disclosure deadline and (2) to grant DCC’s summary-judgment
    motion on the ground that Wisconsin’s statute of limitations bars Gatza’s claims. No. 16-2396
    Appellant’s Br. at 19–21.
    The district court examined similar motions in Sutherland’s action. I:5-cv-30276-DPH
    R. 119 (Order) (Page ID #6264). First, Sutherland requested to amend the expert-disclosure
    deadline, which the district court denied. Id. at 8 (Page ID #6271). Next, the district court
    granted DCC’s motion to exclude the testimony of Sutherland’s three causation experts, Blais,
    Bush, and Fiechtner. Id. at 21 (Page ID #6284). Lastly, the district court granted DCC’s motion
    for summary judgment because (1) Sutherland could not receive punitive damages and (2) she
    could not prove causation without expert testimony. Id. at 24, 26 (Page ID #6287, 6289).
    Sutherland appeals only the district court’s decision not to amend the expert-disclosure deadline.
    No. 16-2397 Appellant’s Br. at 16.
    II. DISCUSSION
    Plaintiffs raise two arguments on appeal. First, Plaintiffs assert that they have shown
    “good cause” to amend the scheduling orders under Federal Rule of Civil Procedure 16(b)(4).
    3
    No. 16-2396/ 2397Gatza et al. v. DCC Litigation Facility, Inc.
    Second, they argue that failing to disclose Brawer by the expert-disclosure deadlines is
    “harmless” under Federal Rule of Civil Procedure 37(c)(1).          We consider each of these
    arguments in turn.
    A. Standard of Review
    We examine a district court’s decision to amend a scheduling order for abuse of
    discretion. Andretti v. Borla Performance Indus., Inc., 
    426 F.3d 824
    , 830 (6th Cir. 2005). The
    same standard applies to reviewing a district court’s decision to issue sanctions for failing to
    disclose a witness. See Baker Hughes Inc. v. S&S Chem., LLC, 
    836 F.3d 554
    , 560 (6th Cir.
    2016).
    B. Rule 16(b)(4)
    A party must disclose his or her expert witnesses by the scheduling-order deadline. Fed.
    R. Civ. P. 26(a)(2)(D). If the party cannot meet that deadline, he or she can move to amend the
    scheduling order. Fed. R. Civ. P. 16(b)(4). When considering a motion to amend, a district court
    will examine (1) whether the moving party has shown “good cause,” 
    id.,
     and (2) whether the
    modification will cause the opposing party to experience possible prejudice, Inge v. Rock Fin.
    Corp., 
    281 F.3d 613
    , 625 (6th Cir. 2002).
    To show good cause, a moving party can demonstrate that he or she diligently attempted
    to meet the original deadline. Leary v. Daeschner, 
    349 F.3d 888
    , 906 (6th Cir. 2003). For this
    issue, there are five factors to consider: “(1) when the moving party learned of the issue that is
    the subject of discovery; (2) how the discovery would affect the ruling below; (3) the length of
    the discovery period; (4) whether the moving party was dilatory; and (5) whether the adverse
    4
    No. 16-2396/ 2397Gatza et al. v. DCC Litigation Facility, Inc.
    party was responsive to . . . discovery requests.” Bentkowski v. Scene Magazine, 
    637 F.3d 689
    ,
    696 (6th Cir. 2011) (omission in original) (quoting Dowling v. Cleveland Clinic Found.,
    
    593 F.3d 472
    , 478 (6th Cir. 2010)). The central question among these factors is whether a party
    acted diligently. Dowling, 
    593 F.3d at 478
    .
    In Gatza’s action, the district court did not abuse its discretion by finding that she had not
    proven “good cause.” When examining the facts, the district court focused on Gatza’s ability to
    comply with the expert-disclosure deadline:
    Gatza admits on remand that her former counsel was able to meet the
    original deadline by timely designating her experts. Gatza therefore cannot meet
    the Leary standard because her counsel was able to meet the original deadline. As
    to Gatza’s citations of articles published after the discovery deadline of 2012,
    Gatza has not shown that her proposed expert relied on these articles for his
    conclusion. Gatza has failed to show that Dr. Brawer was not available or
    identifiable prior to the expert deadline issued by the Court. Gatza has not shown
    that Dr. Brawer was not a known expert at the time the Court issued its expert
    deadline.
    I:05-cv-30496-DPH R. 167 (Order at 6–7) (Page ID #6832–33). Based on these facts, the district
    court found that Gatza had not been diligent, 
    id.,
     and Gatza does not argue that these facts are
    inaccurate, 16-2396 Appellant’s Br. at 35–37. Therefore, the district court did not abuse its
    discretion.1
    For similar reasons, the district court did not abuse its discretion when it found that
    Sutherland had not shown “good cause.” When applying the law, the district court examined
    whether Sutherland could have disclosed Brawer as an expert before the deadline:
    1
    A few days prior to oral argument, Plaintiffs moved that we take judicial notice regarding an article that
    Brawer published in an October 2017 medical journal. We deny this request because the district court did not have
    an opportunity to review this article.
    5
    No. 16-2396/ 2397Gatza et al. v. DCC Litigation Facility, Inc.
    Sutherland admits on remand that her former counsel was able to meet the
    original deadline by timely designating her experts. Sutherland cannot meet the
    Leary standard because her former counsel was able to comply with the original
    deadline. As to Sutherland’s citations of articles published after the discovery
    deadline of 2012, Sutherland has not shown that her proposed expert relied on
    these articles for his conclusion. Sutherland’s proposed expert, Dr. Brawer, has
    admitted that the case reports as shown in these articles, are not accepted as proof
    of a cause and effect relationship between exposure to a substance and disease.
    (Doc. No. 111, Ex. 7, Brown v. Bristol-Meyers Squibb, Case No. 93-10917)
    Sutherland has also failed to show that Dr. Brawer was not available or
    identifiable prior to the original expert deadline issued by the Court. The
    Litigation Facility’s exhibit to its response shows that Dr. Brawer was designated
    as an expert at prior breast implant cases as early as 1993. Id.; see also, Tyson v.
    Minnesota Mining & Manufacturing Co., Case No. 55915-2 T.D. (TN Cir. Ct.,
    Shelby Ct., Oct. 18, 1996) Any proposed expert testimony by Dr. Brawer will not
    be different than his prior testimony in other breast implant cases. Sutherland has
    not shown that Dr. Brawer was not a known expert at the time the Court issued its
    original expert deadline.
    I:05-cv-30276-DPH R. 119 (Order at 6–7) (Page ID #6269–70). This reasoning demonstrates
    that the district court did not rely on clearly erroneous findings of fact. Therefore, the district
    court did not abuse its discretion when it found that Sutherland had not been diligent.
    In summary, for both actions, the district court did not abuse its discretion in finding that
    Plaintiffs did not demonstrate good cause to amend the scheduling order, so we do not need to
    examine whether an amended scheduling order would prejudice DCC.
    C. Rule 37(c)(1)
    We have stated “that an argument not raised before the district court is waived on appeal
    to this Court,” and we “rarely” stray from that rule. Scottsdale Ins. Co. v. Flowers, 
    513 F.3d 546
    ,
    552 (6th Cir. 2008). However, if a case is exceptional or if the application of the rule would
    create a “plain miscarriage of justice,” we might depart from this general rule. 
    Id.
     (quoting
    6
    No. 16-2396/ 2397Gatza et al. v. DCC Litigation Facility, Inc.
    Foster v. Barilow, 
    6 F.3d 405
    , 407 (6th Cir. 1993)). Because Plaintiffs raised their argument
    regarding Rule 37(c)(1) for the first time on appeal and the issue is not novel, we decline to
    address it. No. I:05-cv-30276-DPH R. 97 (Mot. at 7–12) (Page ID #4801–06) (discussing “good
    cause” and “prejudice,” but not “harmless” or Rule 37(c)(1)); No. I:05-cv-30276-DPH R. 102
    (Suppl. Br. at 5–11) (Page ID #4832–38) (same); No. I:05-cv-30496-DHP R. 149 (Mot. at 9–13)
    (Page ID #6073–77) (same); No. I:05-cv-30496-DHP R. 157 (Reply at 5–10) (Page ID #6480–
    85) (same).
    III. CONCLUSION
    We AFFIRM the district court’s judgments based on its denial of Plaintiffs’ motions to
    amend the scheduling orders because (1) the district court did not abuse its discretion by finding
    that Plaintiffs have not demonstrated good cause and (2) Plaintiffs forfeited their argument
    regarding Rule 37(c)(1).
    7